Public Petition for Rulemaking: Replace naloxone co-prescription requirement with FDA-approved opioid-reversal agents
CLOSED Opened on 8/29/2022 and Ended on 9/19/2022
Comment Title | Commenter | |
---|---|---|
Comments in Support of Petition 372 | Todd Lacksonen, Opiant Pharmaceuticals | 9/19/22 2:34 pm |
Updating the term "Naloxone" | Victor McKenzie Jr | 9/19/22 2:24 pm |